Compare Heron Therapeutics Inc (HRTX) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Suncor Energy Inc. — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Suncor Energy Inc. trades at $63.15 (market cap $72.86B). The key difference: Suncor Energy Inc. is far larger — about 796.6× Heron Therapeutics Inc's market cap, and Suncor Energy Inc. pays a 2.71% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | SU | |
|---|---|---|
Market Cap | $91.46M | $72.86B |
Sector | Health | Energy |
52-Week High | $1.96 | $69.73 |
52-Week Low | $0.39 | $38.17 |
Enterprise Value | $189.36M | $80.99B |
Dividend Yield | — | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Suncor Energy (SU) trades at $62.62, up 0.3% with strong technical momentum and bullish analyst sentiment. The stock shows solid fundamentals with a P/E of 16.85, net income margin of 11.62%, and consistent earnings beats in recent quarters. Recent news highlights operational improvements and record production driving the stock's 49% annual gain. Cash flow remains positive with $166M net cash flow in 2025, supported by disciplined capital allocation.
SU presents a compelling investment case with attractive valuation metrics and strong institutional support, though exposure to oil price volatility and recent RSI overbought signals warrant caution. The company's integrated operations and shareholder returns provide stability, but investors should monitor commodity price trends and Q2 earnings results against the $2.14 EPS expectation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
